{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:04:04Z","timestamp":1792659844883,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA226579"],"award-info":[{"award-number":["R21 CA226579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prophylactic mastectomy is the most effective intervention to prevent breast cancer. However, this major surgery has life-changing consequences at the physical, emotional, psychological, and social levels. Therefore, only high-risk individuals consider this aggressive procedure, which completely removes the mammary epithelial cells from which breast cancer arises along with surrounding tissue. Here, we seek to develop a minimally invasive procedure as an alternative to prophylactic mastectomy by intraductal (ID) delivery of a cell-killing solution that locally ablates the mammary epithelial cells before they become malignant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After ID injection of a 70% ethanol-containing solution in FVB\/NJ female animals, ex vivo dual stained whole-mount tissue analysis and in vivo X-ray microcomputed tomography imaging were used to visualize ductal tree filling, and histological and multiplex immunohistochemical assays were used to characterize ablative effects and quantitate the number of intact epithelial cells and stroma. After ID injection of 70% ethanol or other solutions in cancer-prone FVB-Tg-C3(1)-TAg female animals, mammary glands were palpated weekly to establish tumor latency and examined after necropsy to record tumor incidence. Statistical difference in median tumor latency and tumor incidence between experimental groups was analyzed by log-rank test and logistic mixed-effects model, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We report that ID injection of 70% ethanol effectively ablates the mammary epithelia with limited collateral damage to surrounding stroma and vasculature in the murine ductal tree. ID injection of 70% ethanol into the mammary glands of the C3(1)-TAg multifocal breast cancer model significantly delayed tumor formation (median latency of 150\u2009days in the untreated control group [<jats:italic>n<\/jats:italic>\u2009=\u200925] vs. 217\u2009days in the ethanol-treated group [<jats:italic>n<\/jats:italic>\u2009=\u200913], <jats:italic>p<\/jats:italic> value &lt;\u20090.0001) and reduced tumor incidence (34% of glands with tumors [85 of 250] in the untreated control group vs. 7.3% of glands with tumor [7 of 95] in the ethanol-treated group, risk ratio\u2009=\u20094.76 [95% CI 1.89 to 11.97, <jats:italic>p<\/jats:italic> value &lt;\u20090.0001]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This preclinical study demonstrates the feasibility of local ductal tree ablation as a novel strategy for primary prevention of breast cancer. Given the existing clinical uses of ethanol, ethanol-based ablation protocols could be readily implemented in first-in-human clinical trials for high-risk individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13058-019-1217-x","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T18:03:12Z","timestamp":1574964192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ductal tree ablation by local delivery of ethanol prevents tumor formation in an aggressive mouse model of breast cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Elizabeth","family":"Kenyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Westerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatadru","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Claucherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Zaluzec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Madaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galen","family":"Hostetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn","family":"Eagleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2150-0122","authenticated-orcid":false,"given":"Lorenzo F.","family":"Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"issue":"1","key":"1217_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1217_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13058-017-0826-5","volume":"19","author":"TJ Padamsee","year":"2017","unstructured":"Padamsee TJ, Wills CE, Yee LD, Paskett ED. Decision making for breast cancer prevention among women at elevated risk. Breast Cancer Res. 2017;19(1):34.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1217_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1148\/radiographics.21.1.g01ja15133","volume":"21","author":"SH Slawson","year":"2001","unstructured":"Slawson SH, Johnson BA. Ductography: how to and what if? Radiographics. 2001;21(1):133\u201350.","journal-title":"Radiographics"},{"issue":"106","key":"1217_CR4","doi-asserted-by":"publisher","first-page":"106ra108","DOI":"10.1126\/scitranslmed.3002368","volume":"3","author":"V Stearns","year":"2011","unstructured":"Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, et al. Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Sci Transl Med. 2011;3(106):106ra108.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1217_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1158\/1940-6207.CAPR-12-0228","volume":"6","author":"SM Love","year":"2013","unstructured":"Love SM, Zhang W, Gordon EJ, Rao J, Yang H, Li J, Zhang B, Wang X, Chen G, Zhang B. A feasibility study of the intraductal administration of chemotherapy. Cancer Prev Res (Phila). 2013;6(1):51\u20138.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"1217_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10549-015-3614-x","volume":"154","author":"A Gomberawalla","year":"2015","unstructured":"Gomberawalla A, Love S. The 8th international symposium on the breast: using next-generation science to understand the normal breast and the development of breast cancer- conference report. Breast Cancer Res Treat. 2015;154(3):617\u201321.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"1217_CR7","first-page":"646","volume":"11","author":"L Jacobs","year":"2010","unstructured":"Jacobs L, Sukumar S, Stearns V. Intraductal therapy for the prevention of breast cancer. Curr Opin Investig Drugs. 2010;11(6):646\u201352.","journal-title":"Curr Opin Investig Drugs"},{"issue":"1","key":"1217_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1067\/j.cpradiol.2015.05.007","volume":"45","author":"LS Sheiman","year":"2016","unstructured":"Sheiman LS, Levesque PH. The in\u2019s and out\u2019s of ductography: a comprehensive review. Curr Probl Diagn Radiol. 2016;45(1):61\u201370.","journal-title":"Curr Probl Diagn Radiol"},{"issue":"2","key":"1217_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jmu.2014.04.006","volume":"22","author":"Mein-Kai Gueng","year":"2014","unstructured":"Gueng M-K, Chou Y-H, Tiu C-M, Chiou S-Y, Cheng Y-F. Pseudoaneurysm of the breast treated with percutaneous ethanol injection. J Med Ultrasound. 2014;22(2):114\u20136.","journal-title":"Journal of Medical Ultrasound"},{"issue":"2","key":"1217_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1158\/0008-5472.CAN-05-4329","volume":"66","author":"S Murata","year":"2006","unstructured":"Murata S, Kominsky SL, Vali M, Zhang Z, Garrett-Mayer E, Korz D, Huso D, Baker SD, Barber J, Jaffee E, et al. Ductal access for prevention and therapy of mammary tumors. Cancer Res. 2006;66(2):638\u201345.","journal-title":"Cancer Res"},{"issue":"1","key":"1217_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1015227719105","volume":"73","author":"L Sivaraman","year":"2002","unstructured":"Sivaraman L, Gay J, Hilsenbeck SG, Shine HD, Conneely OM, Medina D, O'Malley BW. Effect of selective ablation of proliferating mammary epithelial cells on MNU induced rat mammary tumorigenesis. Breast Cancer Res Treat. 2002;73(1):75\u201383.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1217_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10549-004-6455-6","volume":"91","author":"H Okugawa","year":"2005","unstructured":"Okugawa H, Yamamoto D, Uemura Y, Sakaida N, Tanano A, Tanaka K, Kamiyama Y. Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S-D rats. Breast Cancer Res Treat. 2005;91(1):29\u201334.","journal-title":"Breast Cancer Res Treat"},{"issue":"22","key":"1217_CR13","doi-asserted-by":"publisher","first-page":"33306","DOI":"10.18632\/oncotarget.8949","volume":"7","author":"T Yoshida","year":"2016","unstructured":"Yoshida T, Jin K, Song H, Park S, Huso DL, Zhang Z, Liangfeng H, Zhu C, Bruchertseifer F, Morgenstern A, et al. Effective treatment of ductal carcinoma in situ with a HER-2-targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer. Oncotarget. 2016;7(22):33306\u201315.","journal-title":"Oncotarget"},{"issue":"1","key":"1217_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10549-012-2138-x","volume":"135","author":"YS Chun","year":"2012","unstructured":"Chun YS, Yoshida T, Mori T, Huso DL, Zhang Z, Stearns V, Perkins B, Jones RJ, Sukumar S. Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors. Breast Cancer Res Treat. 2012;135(1):201\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"1217_CR15","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/carcin\/bgs248","volume":"33","author":"YS Chun","year":"2012","unstructured":"Chun YS, Bisht S, Chenna V, Pramanik D, Yoshida T, Hong SM, de Wilde RF, Zhang Z, Huso DL, Zhao M, et al. Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis. 2012;33(11):2242\u20139.","journal-title":"Carcinogenesis"},{"issue":"217","key":"1217_CR16","doi-asserted-by":"publisher","first-page":"217ra212","DOI":"10.1126\/scitranslmed.3007048","volume":"6","author":"A Brock","year":"2014","unstructured":"Brock A, Krause S, Li H, Kowalski M, Goldberg MS, Collins JJ, Ingber DE. Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci Transl Med. 2014;6(217):217ra212.","journal-title":"Sci Transl Med"},{"issue":"7","key":"1217_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/carcin\/bgz084","volume":"40","author":"Guannan Wang","year":"2019","unstructured":"Wang G, Chen C, Pai P, Korangath P, Sun S, Merino VF, Yuan J, Li S, Nie G, Stearns V, et al. Intraductal fulvestrant for therapy of ERalphapositive ductal carcinoma in situ (DCIS) of the breast- a preclinical study. Carcinogenesis. 2019;40(7):903-13.","journal-title":"Carcinogenesis"},{"issue":"2","key":"1217_CR18","first-page":"306","volume":"16","author":"WW Teo","year":"2014","unstructured":"Teo WW, Sukumar S. Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment. Breast Cancer Res. 2014;16(2):306.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1217_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jmu.2014.04.006","volume":"22","author":"Mein-Kai Gueng","year":"2014","unstructured":"Gueng M-K, Chou Y-H, Tiu C-M, Chiou S-Y, Cheng Y-F. Pseudoaneurysm of the breast treated with percutaneous ethanol injection. J Med Ultrasound. 22(2):114\u20136.","journal-title":"Journal of Medical Ultrasound"},{"issue":"2","key":"1217_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1148\/radiol.2532082021","volume":"253","author":"M Kuang","year":"2009","unstructured":"Kuang M, Lu MD, Xie XY, Xu HX, Xu ZF, Liu GJ, Yin XY, Huang JF, Lencioni R. Ethanol ablation of hepatocellular carcinoma up to 5.0 cm by using a multipronged injection needle with high-dose strategy. Radiology. 2009;253(2):552\u201361.","journal-title":"Radiology"},{"issue":"10","key":"1217_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3748\/wjg.v18.i10.1003","volume":"18","author":"D Ansari","year":"2012","unstructured":"Ansari D, Andersson R. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. World J Gastroenterol. 2012;18(10):1003\u20138.","journal-title":"World J Gastroenterol"},{"issue":"22","key":"1217_CR22","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.3748\/wjg.v19.i22.3397","volume":"19","author":"WY Zhang","year":"2013","unstructured":"Zhang WY, Li ZS, Jin ZD. Endoscopic ultrasound-guided ethanol ablation therapy for tumors. World J Gastroenterol. 2013;19(22):3397\u2013403.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1217_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14309\/crj.2015.92","volume":"3","author":"M Chin","year":"2015","unstructured":"Chin M, Chen CL, Chang K, Lee J, Samarasena J. Ethanol ablation of a peripheral nerve sheath tumor presenting as a small bowel obstruction. ACG Case Rep J. 2015;3(1):31\u20132.","journal-title":"ACG Case Rep J"},{"issue":"6","key":"1217_CR24","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00330-016-4603-0","volume":"27","author":"WA Wohlgemuth","year":"2017","unstructured":"Wohlgemuth WA, Muller-Wille R, Teusch V, Hammer S, Wildgruber M, Uller W. Ethanolgel sclerotherapy of venous malformations improves health-related quality-of-life in adults and children - results of a prospective study. Eur Radiol. 2017;27(6):2482\u20138.","journal-title":"Eur Radiol"},{"issue":"10","key":"1217_CR25","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/ans.12833","volume":"86","author":"F Steiner","year":"2016","unstructured":"Steiner F, FitzJohn T, Tan ST. Ethanol sclerotherapy for venous malformation. ANZ J Surg. 2016;86(10):790\u20135.","journal-title":"ANZ J Surg"},{"issue":"2","key":"1217_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/159101990401000203","volume":"10","author":"K Sannier","year":"2004","unstructured":"Sannier K, Dompmartin A, Theron J, Labbe D, Barrellier MT, Leroyer R, Toure P, Leroy D. A new sclerosing agent in the treatment of venous malformations. Study on 23 cases. Interv Neuroradiol. 2004;10(2):113\u201327.","journal-title":"Interv Neuroradiol"},{"issue":"12","key":"1217_CR27","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s00330-011-2213-4","volume":"21","author":"A Dompmartin","year":"2011","unstructured":"Dompmartin A, Blaizot X, Theron J, Hammer F, Chene Y, Labbe D, Barrellier MT, Gaillard C, Leroyer R, Chedru V, et al. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol. 2011;21(12):2647\u201356.","journal-title":"Eur Radiol"},{"issue":"2","key":"1217_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3892\/etm.2013.1144","volume":"6","author":"J Zhang","year":"2013","unstructured":"Zhang J, Li HB, Zhou SY, Chen KS, Niu CQ, Tan XY, Jiang YZ, Lin QQ. Comparison between absolute ethanol and bleomycin for the treatment of venous malformation in children. Exp Ther Med. 2013;6(2):305\u20139.","journal-title":"Exp Ther Med"},{"issue":"issue","key":"1217_CR29","first-page":"80","volume":"80","author":"S Krause","year":"2013","unstructured":"Krause S, Brock A, Ingber DE. Intraductal injection for localized drug delivery to the mouse mammary gland. J Vis Exp. 2013;80(issue):80.","journal-title":"J Vis Exp"},{"key":"1217_CR30","doi-asserted-by":"crossref","unstructured":"Plante I, Stewart MK, Laird DW. Evaluation of mammary gland development and function in mouse models. J Vis Exp. 2011;53:e2828.","DOI":"10.3791\/2828"},{"key":"1217_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-4939-1459-3_13","volume":"1211","author":"LF Sempere","year":"2014","unstructured":"Sempere LF. Fully automated fluorescence-based four-color multiplex assay for co-detection of microRNA and protein biomarkers in clinical tissue specimens. Methods Mol Biol. 2014;1211:151\u201370.","journal-title":"Methods Mol Biol"},{"issue":"7","key":"1217_CR32","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","volume":"74","author":"JL Lines","year":"2014","unstructured":"Lines JL, Pantazi E, Mak J, Sempere LF, Wang L, O'Connell S, Ceeraz S, Suriawinata AA, Yan S, Ernstoff MS, et al. VISTA is an immune checkpoint molecule for human T cells. Cancer Res. 2014;74(7):1924\u201332.","journal-title":"Cancer Res"},{"key":"1217_CR33","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat. 2015;67(1):48."},{"issue":"6","key":"1217_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/bcr1331","volume":"7","author":"L Hinck","year":"2005","unstructured":"Hinck L, Silberstein GB. Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res. 2005;7(6):245\u201351.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1217_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10911-017-9372-0","volume":"22","author":"IS Paine","year":"2017","unstructured":"Paine IS, Lewis MT. The terminal end bud: the little engine that could. J Mammary Gland Biol Neoplasia. 2017;22(2):93\u2013108.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"22","key":"1217_CR36","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1101\/gad.1849509","volume":"23","author":"JE Visvader","year":"2009","unstructured":"Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev. 2009;23(22):2563\u201377.","journal-title":"Genes Dev"},{"issue":"5","key":"1217_CR37","first-page":"553","volume":"52","author":"JC Ingrao","year":"2013","unstructured":"Ingrao JC, Johnson R, Tor E, Gu Y, Litman M, Turner PV. Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL\/6 mice. J Am Assoc Lab Anim Sci. 2013;52(5):553\u20139.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"1217_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-cellbio-092910-154251","volume":"27","author":"KJ Sonnemann","year":"2011","unstructured":"Sonnemann KJ, Bement WM. Wound repair: toward understanding and integration of single-cell and multicellular wound responses. Annu Rev Cell Dev Biol. 2011;27:237\u201363.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"1217_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajpath.2010.08.003","volume":"178","author":"SK Brancato","year":"2011","unstructured":"Brancato SK, Albina JE. Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol. 2011;178(1):19\u201325.","journal-title":"Am J Pathol"},{"issue":"8","key":"1217_CR40","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/sj.onc.1203280","volume":"19","author":"JE Green","year":"2000","unstructured":"Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, et al. The C3(1)\/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene. 2000;19(8):1020\u20137.","journal-title":"Oncogene"},{"issue":"2","key":"1217_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/bcr1410","volume":"8","author":"BL King","year":"2006","unstructured":"King BL, Love SM. The intraductal approach to the breast: raison d'etre. Breast Cancer Res. 2006;8(2):206.","journal-title":"Breast Cancer Res"},{"issue":"9","key":"1217_CR42","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/cncr.20559","volume":"101","author":"SM Love","year":"2004","unstructured":"Love SM, Barsky SH. Anatomy of the nipple and breast ducts revisited. Cancer. 2004;101(9):1947\u201357.","journal-title":"Cancer"},{"issue":"1","key":"1217_CR43","doi-asserted-by":"publisher","first-page":"8750","DOI":"10.1038\/s41598-017-09371-2","volume":"7","author":"R Morhard","year":"2017","unstructured":"Morhard R, Nief C, Barrero Castedo C, Hu F, Madonna M, Mueller JL, Dewhirst MW, Katz DF, Ramanujam N. Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors. Sci Rep. 2017;7(1):8750.","journal-title":"Sci Rep"},{"issue":"7687","key":"1217_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature25154","volume":"553","author":"JI Garaycoechea","year":"2018","unstructured":"Garaycoechea JI, Crossan GP, Langevin F, Mulderrig L, Louzada S, Yang F, Guilbaud G, Park N, Roerink S, Nik-Zainal S, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553(7687):171\u20137.","journal-title":"Nature"},{"issue":"20","key":"1217_CR45","first-page":"7449","volume":"61","author":"JE Green","year":"2001","unstructured":"Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R. 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)\/SV40 T\/t-antigen transgenic mice. Cancer Res. 2001;61(20):7449\u201355.","journal-title":"Cancer Res"},{"key":"1217_CR46","doi-asserted-by":"crossref","unstructured":"Rutkowski MR, Allegrezza MJ, Svoronos N, Tesone AJ, Stephen TL, Perales-Puchalt A, Nguyen J, Zhang PJ, Fiering SN, Tchou J, et al. Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer. J Vis Exp. 2014;85:e51171.","DOI":"10.3791\/51171"},{"issue":"24","key":"1217_CR47","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1242\/dev.059261","volume":"137","author":"AC Chua","year":"2010","unstructured":"Chua AC, Hodson LJ, Moldenhauer LM, Robertson SA, Ingman WV. Dual roles for macrophages in ovarian cycle-associated development and remodelling of the mammary gland epithelium. Development. 2010;137(24):4229\u201338.","journal-title":"Development"},{"issue":"4","key":"1217_CR48","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.bjc.6604534","volume":"99","author":"OJ Vilholm","year":"2008","unstructured":"Vilholm OJ, Cold S, Rasmussen L, Sindrup SH. The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer. Br J Cancer. 2008;99(4):604\u201310.","journal-title":"Br J Cancer"},{"issue":"5","key":"1217_CR49","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1503\/cjs.000716","volume":"59","author":"D Waltho","year":"2016","unstructured":"Waltho D, Rockwell G. Post-breast surgery pain syndrome: establishing a consensus for the definition of post-mastectomy pain syndrome to provide a standardized clinical and research approach - a review of the literature and discussion. Can J Surg. 2016;59(5):342\u201350.","journal-title":"Can J Surg"},{"key":"1217_CR50","doi-asserted-by":"crossref","unstructured":"Clark A, Bird NK, Brock A. Intraductal delivery to the rabbit mammary gland. J Vis Exp. 2017;121:e55209.","DOI":"10.3791\/55209"},{"issue":"1","key":"1217_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10334-013-0409-0","volume":"27","author":"R Borowiak","year":"2014","unstructured":"Borowiak R, Groebner J, Haas M, Hennig J, Bock M. Direct cerebral and cardiac 17O-MRI at 3 Tesla: initial results at natural abundance. MAGMA. 2014;27(1):95\u20139.","journal-title":"MAGMA"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-019-1217-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-019-1217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:38:09Z","timestamp":1606437489000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-019-1217-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1186\/s13058-019-1217-x","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were conducted under protocols approved by the Institutional Animal Care and Use Committee at Van Andel Research Institute and\/or Michigan State University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}